TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study.

Anuja Pandit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.